SCHEMBL22678558

SCHEMBL22678558

CCOC(=O)c1nc(-c2ccc(OC(F)F)cc2)[nH]c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
TP53 P04637 1/20 0.56
HSD17B10 Q99714 1/20 0.56
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HPGD P15428 1/20 0.48
POLB P06746 1/20 0.48
GLA P06280 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 2/20 0.45
PIN1 Q13526 2/20 0.44
TARBP2 Q15633 3/20 0.42
PDCD4 Q53EL6 1/20 0.42
HCRTR1 O43613 1/20 0.41
SIRT2 Q8IXJ6 3/20 0.41
SIRT1 Q96EB6 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28297325 0.85 KDM4E (0.60) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL22678319 0.85 PIN1 (0.62) KDM4EALDH1A1LMNAGAANPSR1
SCHEMBL4382123 0.84 KDM4E (0.57) KDM4ESMN1; SMN2TP53HSD17B10POLB
SCHEMBL27475261 0.80 PIN1 (0.68) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL17803252 0.80 KDM4E (0.58) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL22658075 0.76 TARBP2 (0.73) KDM4ESMN1; SMN2HSD17B10ALDH1A1LMNA
SCHEMBL22658109 0.74 TARBP2 (0.51) KDM4ESMN1; SMN2HSD17B10ALDH1A1LMNA
SCHEMBL15864834 0.72 CA12 (0.58) SMN1; SMN2ALDH1A1LMNAHPGDPOLB
SCHEMBL22678248 0.72 MAPT (0.46) SMN1; SMN2LMNANPSR1MAPTHTT
SCHEMBL2817928 0.72 ALOX5 (0.54) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127049-A ACSS2 inhibitors and methods of use thereof 美特波米德有限公司 2022-03-01 CN disclosed
WO-2020230134-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF METABOMED LTD (IL) 2020-11-19 WO disclosed